EQUITABLE POPULATION HEALTH MANAGEMENT FOR CHRONIC DISEASES

Higia uses the Power of Artificial Intelligence to Predict Who Will Soon Develop Chronic Diseases, Driving Early Interventions.

Slide 1 of 3

In 5 years, practice without AI will be mal practice

In US, the annual economic impact of Chronic Diseases is estimated to be $1.3 trillion, turning into $6 trillion by 2050

Chronic Diseases account for 75% of US Healthcare Costs

In 5 years, practice without AI will be mal practice

In US, the annual economic impact of Chronic Diseases is estimated to be $1.3 trillion, turning into $6 trillion by 2050

Chronic Diseases account for 75% of US Healthcare Costs

In 5 years, practice without AI will be mal practice

In US, the annual economic impact of Chronic Diseases is estimated to be $1.3 trillion, turning into $6 trillion by 2050

Chronic Diseases account for 75% of US Healthcare Costs

People-centric AI Solutions for Healthcare

Higia's AI solutions provide personalized healthcare by analyzing patient data from multiple sources to identify individual risk factors and predict the likelihood of developing certain conditions. This enables patients and healthcare professionals to take proactive measures to prevent or manage chronic diseases by providing tailored recommendations and intervention opportunities, such as lifestyle changes, medication adjustments, or additional screenings.

Bringing the right patient, to the right clinicians, on the right time

Savings

Optimization of every dollar spent to keep members healthy, while generating savings since the first year.

Improved Population Health

Identifying patients at Risk, enabling preventive treatments and improving future life quality.

Precision Medicine

We assist doctors in identifying specific disease risks and treatment options for their patients.

Large Clinical Model

Higia is committed to advancing healthcare by delivering cutting-edge AI solutions that prioritize patient data security, privacy, and accessibility. Our use of state-of-the-art Artificial Intelligence methods, such as Federated Learning, enables us to achieve this goal while creating more accurate Predictive Super Models for Chronic Diseases.

Federated Learning is a powerful artificial intelligence technique that allows us to combine data from multiple sources without having to share patient information, protecting privacy and allowing us to create a Large Clinical Supermodel that can help predict and prevent chronic diseases.

Explainable & Equitable AI

Explainable Artificial Intelligence solves the black-box problem of AI by providing explanations of how the system arrived at its decision and presents them in a way that humans can understand. These insights can assist in identifying biases in the decision-making process, leading to more efficient, accurate, trustworthy and equitable healthcare delivery.

As AI becomes more integrated into our daily lives, the need for transparency and accountability will only become more important. By embracing Explainable AI, we can ensure that these powerful technologies are used ethically and responsibly, for the benefit of all.

Scientific Excellence

Higia’s medical team comprises accomplished and globally recognized experts in the field of Chronic Diseases. Each possessing vast experience in the diagnosis, treatment, and management of these complex conditions. At the forefront of our team’s ethos is a steadfast commitment to innovation, driven by a passion for discovering the latest research and breakthroughs in the field of medicine.

Our team is dedicated to applying this knowledge to the development of cutting-edge AI products that are medically applicable in daily clinical operations. By leveraging the new possibilities enabled today by Artificial Intelligence, our products are designed to provide actionable insights that enhance patient care, improve outcomes, and drive innovation in the field of Chronic Diseases.

Slide 1 of 9

$1 out of every $4 in US health care costs is spent on caring for people with diabetes

Worldwide, there are estimated to be over 650 million individuals dealing with morbid obesity

96 Million people in the US have prediabetes and 80% are unaware

23% of Diabetics are undiagnosed in the US

37 Million People in the USA Affected by Kidney Disease, with 80% Undiagnosed

Diabetes Kills One Person Every Six Seconds

25% of the 'Healthy' Population Suffers from Fatty Liver Disease

Cardiovascular Diseases: The Leading Global Cause of Death, Accounting for Approximately 31% of All Mortalities

In the global context, hypertension affects over one billion individuals

$1 out of every $4 in US health care costs is spent on caring for people with diabetes

Worldwide, there are estimated to be over 650 million individuals dealing with morbid obesity

96 Million people in the US have prediabetes and 80% are unaware

23% of Diabetics are undiagnosed in the US

37 Million People in the USA Affected by Kidney Disease, with 80% Undiagnosed

Diabetes Kills One Person Every Six Seconds

25% of the 'Healthy' Population Suffers from Fatty Liver Disease

Cardiovascular Diseases: The Leading Global Cause of Death, Accounting for Approximately 31% of All Mortalities

In the global context, hypertension affects over one billion individuals

$1 out of every $4 in US health care costs is spent on caring for people with diabetes

Worldwide, there are estimated to be over 650 million individuals dealing with morbid obesity

96 Million people in the US have prediabetes and 80% are unaware

23% of Diabetics are undiagnosed in the US

37 Million People in the USA Affected by Kidney Disease, with 80% Undiagnosed

Diabetes Kills One Person Every Six Seconds

25% of the 'Healthy' Population Suffers from Fatty Liver Disease

Cardiovascular Diseases: The Leading Global Cause of Death, Accounting for Approximately 31% of All Mortalities

In the global context, hypertension affects over one billion individuals

Empowering doctors and patients to win the battle against chronic diseases by providing the right action and the right time

About us

Higia is a privately held company with a global footprint and headquarters in Barcelona. Complementing its international reach, Higia has established a significant presence in the United States, LATAM, and the Middle East.

Our team of AI experts brings over a decade of experience developing AI solutions for various markets and have worked on complex AI projects with large corporations.

To ensure that our products remain at the forefront of innovation and maintain the highest level of medical applicability, we have a medical advisory team and a network of affiliated medical research partners who are leaders in their respective fields.

At Higia, we are passionate about leveraging our expertise in AI and biotech to make a positive impact on society. Our close-knit team of experts and our unwavering dedication to innovation and medical relevance set us apart as a unique and valuable player in the industry.

Contact Higia

Get in touch with our experts and know how AI can help your patients.